CMS to work close­ly with FDA on ac­cel­er­at­ed ap­proval pay­ment re­forms

The FDA has his­tor­i­cal­ly not dealt with drug pric­ing, un­less it’s re­lat­ed to sav­ings from gener­ic drug com­pe­ti­tion.

But that’s slow­ly chang­ing now, with CMS …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER